FR2326205A1 - Methode pour detecter des antigenes et anticorps de l'hepatite et vaccin contre l'hepatite - Google Patents
Methode pour detecter des antigenes et anticorps de l'hepatite et vaccin contre l'hepatiteInfo
- Publication number
- FR2326205A1 FR2326205A1 FR7629413A FR7629413A FR2326205A1 FR 2326205 A1 FR2326205 A1 FR 2326205A1 FR 7629413 A FR7629413 A FR 7629413A FR 7629413 A FR7629413 A FR 7629413A FR 2326205 A1 FR2326205 A1 FR 2326205A1
- Authority
- FR
- France
- Prior art keywords
- hepatitis
- antibodies
- vaccine against
- detecting antigens
- against hepatitis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 208000006454 hepatitis Diseases 0.000 title 2
- 231100000283 hepatitis Toxicity 0.000 title 2
- 239000000427 antigen Substances 0.000 title 1
- 102000036639 antigens Human genes 0.000 title 1
- 108091007433 antigens Proteins 0.000 title 1
- 229960005486 vaccine Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/29—Hepatitis virus
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2730/00—Reverse transcribing DNA viruses
- C12N2730/00011—Details
- C12N2730/10011—Hepadnaviridae
- C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
- C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2730/00—Reverse transcribing DNA viruses
- C12N2730/00011—Details
- C12N2730/10011—Hepadnaviridae
- C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
- C12N2730/10134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/32011—Picornaviridae
- C12N2770/32411—Hepatovirus, i.e. hepatitis A virus
- C12N2770/32422—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/32011—Picornaviridae
- C12N2770/32411—Hepatovirus, i.e. hepatitis A virus
- C12N2770/32434—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/82—Hepatitis associated antigens and antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Virology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Urology & Nephrology (AREA)
- Biochemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Hematology (AREA)
- Mycology (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Communicable Diseases (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US05/618,644 US4100267A (en) | 1975-10-01 | 1975-10-01 | Method of detecting hepatitis B core antigen and antibody |
Publications (1)
Publication Number | Publication Date |
---|---|
FR2326205A1 true FR2326205A1 (fr) | 1977-04-29 |
Family
ID=24478533
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR7629413A Withdrawn FR2326205A1 (fr) | 1975-10-01 | 1976-09-30 | Methode pour detecter des antigenes et anticorps de l'hepatite et vaccin contre l'hepatite |
Country Status (10)
Country | Link |
---|---|
US (1) | US4100267A (fr) |
JP (1) | JPS5244230A (fr) |
AU (1) | AU1807776A (fr) |
BE (1) | BE846822A (fr) |
DE (1) | DE2644493A1 (fr) |
DK (1) | DK439576A (fr) |
FR (1) | FR2326205A1 (fr) |
NL (1) | NL7610853A (fr) |
NO (1) | NO763344L (fr) |
SE (1) | SE7610839L (fr) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4241175A (en) * | 1978-12-18 | 1980-12-23 | Merck & Co., Inc. | Assay for hepatitis B core antibody |
US6268122B1 (en) | 1978-12-22 | 2001-07-31 | Biogen, Inc. | Recombinant DNA molecules and their method of production |
US4464474A (en) * | 1980-07-09 | 1984-08-07 | Connaught Laboratories Limited | Non-A, non-B hepatitis assay and vaccine |
US5866383A (en) * | 1982-11-30 | 1999-02-02 | The United States Of America As Represented By The Department Of Health And Human Services | In vitro ligation of foreign DNA into large eukaryotic viruses |
US4547367A (en) * | 1983-12-20 | 1985-10-15 | The United States Of America As Represented By The Department Of Health And Human Services | Hepatitis B core antigen vaccine |
US4547368A (en) * | 1983-12-20 | 1985-10-15 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Hepatitis B core antigen vaccine made by recombinant DNA |
US4752567A (en) * | 1984-06-21 | 1988-06-21 | Janssen Pharmaceutica N.V. | Method of visualizing individual submicroscopic metal particles |
GB8604985D0 (en) * | 1986-02-28 | 1986-04-09 | Unilever Plc | Precipitated silicas |
JPH085804B2 (ja) * | 1988-04-28 | 1996-01-24 | 財団法人化学及血清療法研究所 | A型及びb型肝炎混合アジュバントワクチン |
DE4422238C2 (de) * | 1994-06-24 | 1996-05-30 | Behringwerke Ag | Verfahren zur Isolierung einer Antigenpräparation |
CN1500140A (zh) * | 2001-03-28 | 2004-05-26 | 上海晶泰生物技术有限公司 | 用于测试多种待分析物的装置及方法 |
-
1975
- 1975-10-01 US US05/618,644 patent/US4100267A/en not_active Expired - Lifetime
-
1976
- 1976-09-23 AU AU18077/76A patent/AU1807776A/en not_active Expired
- 1976-09-29 DK DK439576A patent/DK439576A/da unknown
- 1976-09-30 NL NL7610853A patent/NL7610853A/xx not_active Application Discontinuation
- 1976-09-30 BE BE171143A patent/BE846822A/fr unknown
- 1976-09-30 SE SE7610839A patent/SE7610839L/xx unknown
- 1976-09-30 NO NO763344A patent/NO763344L/no unknown
- 1976-09-30 FR FR7629413A patent/FR2326205A1/fr not_active Withdrawn
- 1976-10-01 JP JP51117354A patent/JPS5244230A/ja active Pending
- 1976-10-01 DE DE19762644493 patent/DE2644493A1/de active Pending
Also Published As
Publication number | Publication date |
---|---|
DK439576A (da) | 1977-04-02 |
US4100267A (en) | 1978-07-11 |
SE7610839L (sv) | 1977-04-02 |
DE2644493A1 (de) | 1977-04-14 |
BE846822A (fr) | 1977-03-30 |
JPS5244230A (en) | 1977-04-07 |
AU1807776A (en) | 1978-04-06 |
NO763344L (fr) | 1977-04-04 |
NL7610853A (nl) | 1977-04-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FR2274047A1 (fr) | Nouveau procede de detection de la presence d'antigenes et d'anticorps | |
FR2322373A1 (fr) | Methode et necessaire de dosage immunologique d'un antigene en phase solide | |
BE849593A (nl) | Roetbevattende pigmenten en werkwijze voor de bereiding daarvan | |
FR2344629A1 (fr) | Procede pour la purification et l'isolement de virus de l'hepatite utilisable pour la preparation d'un vaccin | |
JPS5283933A (en) | Serum physiological method for detecting presence of nigeria gonoroe antigen | |
IL45707A0 (en) | Method of detecting antigens or antibodies | |
FR2319131A1 (fr) | Procede pour detecter et separer les antigenes et les anticorps dans le sang ou autres echantillons | |
SE405961B (sv) | Sett och anordning for orientering och frammatning av forslutningskapsyler eller dylikt | |
LU79477A1 (fr) | Procedes de preparation de l'antigene du noyau d'hepatite b et de vaccins le contenant | |
FR2326205A1 (fr) | Methode pour detecter des antigenes et anticorps de l'hepatite et vaccin contre l'hepatite | |
BE863810A (fr) | Procede de preparation d'un antigene et d'un anticorps | |
SE7606789L (sv) | Sett och anordning for noggrann avmetning av radioaktiv losningar | |
CY1034A (en) | Hepatitis b antigen and method of producing it | |
FR2301825A1 (fr) | Detection de l'antigene de surface de l'hepatite b par agglutination de latex | |
FR2302304A1 (fr) | Antigenes et anticorps de catecholamines | |
BE839306A (fr) | Vaccin d'immunisation active contre l'hepatite virale et procede de preparation | |
SE7604317L (sv) | Fast farmaceutisk doseringsform med fordrojd frigoring och sett att framstella desamma | |
PT73032A (fr) | Procede pour isoler des antigenes glycoproteiques viraux et son application a la preparation de vaccins | |
NO151315C (no) | Fremgangsmaate og anordning for fremstilling av roerformet eske med innbrettbare endefliker | |
BE836156A (fr) | Vaccin contre les oreillons et son procede de preparation | |
BE858406A (fr) | Nouveau procede de dosage d'antigenes et d'anticorps | |
JPS5667757A (en) | Method of detecting and determining hapten and antigen | |
SE7611686L (sv) | Disubstituerade fenoletrar av 3-amino-2-hydroxipropan och sett for deras framstellning | |
BE769356A (fr) | Procede de preparation et application d'un nouveau vaccin antivariolique exempt d'eau et directement applicable | |
JPS5269381A (en) | Method of magnetically detecting flaw |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ST | Notification of lapse |